Treatment of guttural pouch mycosis with salpingopharyngostomy
Amanda R Watkins1 and Eric J
Parente1
1University of Pennsylvania New Bolton Center, Kennett
Square PA
The case report by Rowe et al (2023) published in this issue
describes a case of bilateral guttural pouch mycosis in a 9-month-old
thoroughbred colt that was diagnosed due to unusual severe neurologic
abnormalities including neck pain and abnormal head carriage. There was
no evidence of hemorrhage in this case and therefore the colt was
treated with debridement of the mycotic plaques, topical enilconazole,
and ultimately a salpingopharyngeal fistula in the dorsal pharyngeal
recess to inhibit the growth of the mycosis. The treatments were
successful, and the colt went on to race.
The guttural pouch is an diverticulum of the auditory tube that is found
in ungulates possessing an odd number of toes, including the
horse.1 The guttural pouches are susceptible to fungal
and bacterial infections and the intimate association of the pouches
with major arteries and nerves makes such infections potentially
life-threatening. While the purpose of the guttural pouch is an area of
speculation among equine researchers it is thought that cooling the
blood before it reaches the brain especially during exercise is an
important function.1 The cooling of the blood is
achieved by a large air filled space separated from the internal carotid
artery by only a thin membrane. Therefore, any locally invasive disease
within the guttural pouches can have dire consequences.
Fungal infection of the guttural pouch occurs rarely but, due to its
anatomical position in relation to many neurovascular structures of the
head, even mild disease can result in fatal hemorrhage and neurological
sequelae.2 Obtaining a positive culture from these
cases can be difficult however the most commonly isolated fungal species
is Aspergillus fumigatus.2 The warm, dark, and humid
environment of the guttural pouch may predispose it as a site of fungal
infection. Jukic et al showed that the oxygen and carbon dioxide
partial pressures within the guttural pouch vary significantly between
horses and that they remain relatively static throughout the respiratory
cycle in a normal guttural pouch.3 This inter-horse
variation may explain the seemingly random distribution of horses that
are affected by guttural pouch mycosis. Additionally the individual
differences may contribute to the less aggressive phenotype that
resolves without treatment in 15-28 days that is seen in the
experimentally induced Aspergillus guttural pouch mycosis
model.4 The case described in this report may have
been complicated by the mixed infection cultured from the guttural pouch
of both Aspergillus fumigatus and Streptococcus equi subsp.
zooepidemicus .
Salpingopharyngostomy is the creation of a fistula between the pharynx
and the guttural pouch and has been described as a treatment for
guttural pouch mycosis.3,5–7 The theory behind this
procedure is that it opens the guttural pouch to the fluctuating change
of respiratory gases and temperatures of the respiratory tract. Jukicet al demonstrated that following salpingopharyngostomy there was
no difference in the mean partial pressures of oxygen and carbon dioxide
within the guttural pouch however, the variability of the pressures was
significantly increased with the partial pressures oscillating with the
respiratory pattern.3 This introduction of varying gas
levels may change the environment within the guttural pouches making
them less hospitable to fungal growth and allowing for faster resolution
of the infection. In this case, due to the bilateral nature of the
disease the authors created a single salpingopharyngostomy in the dorsal
pharyngeal recess to gain access to both guttural pouches
simultaneously. Creating a bilateral opening is easily created and can
even be made larger and more likely to remain patent by ablating part of
the septum between the two pouches.
Aspergillus species are highly aerobic and can grow in most oxygen
environments. However, they are also capable of growing at low oxygen
tension and growth under these conditions may affect their pathogenicity
by allowing secretion of virulence factors.8Hyperbaric oxygen treatment of A. fumigatus biofilms in
vitro resulted in decreased biofilm proliferation by over 50%, though
the effect was transient with growth re-establishing at 6 hours post
treatment.9 In human medicine, individuals with
invasive fungal infections caused by Aspergillus spp . are
routinely treated with hyperbaric oxygen therapy in addition to surgical
debridement and anti-fungal medications.10 Though
there is a lack of controlled evidence to support this therapeutic in
fungal infection, the complications are minimal and it is thought to
improve the efficacy of neutrophils and macrophages by meeting their
increased oxygen demands when clearing infections.11Additionally increased oxygen may improve the quality of the collagen
matrix being created during the healing process.11
An additional therapeutic that might have been helpful in this case
prior to salpingopharyngeal fistulation is topical oxygen therapy (TOT)
which has been recently published by Lepage et al for use as an
adjunct treatment in epistaxis cases following transarterial coil
embolization (TACE) or as a primary treatment in non-bleeding
cases.12 Part of the rationale behind pursuing
additional treatment options by this group is the percentage of horses
that fail to completely resolve the neurologic sequelae of the disease
which has been reported at 50%.13 When examining the
issue of recurrent epistaxis following TACE the survival rate is 84%
which places this high level of persistent neurological abnormalities
into sharp relief. Dysphagia particularly can be severe enough to
necessitate euthanasia even in the face of successful hemorrhage
management. Certainly, dysphagia can be reversible as in the case
published by Whitehead et al that was managed successfully with
topical anti-fungals, carotid occlusion and esophagostomy but it can be
a lengthy process that not all owners or patients will
tolerate.14
Guttural pouch mycosis does not lend itself to aggressive surgical
debridement given the closely associated vessels and nerves to the
mycotic plaques, however the somewhat enclosed environment of the
guttural pouch may be an advantage for TOT. Lepage et al treated
cases with TOT 4 times per day at 15 L/min for 1-2 weeks by placing an
indwelling catheter into the affected guttural pouch and leaving it in
place as much as possible for the duration of hospitalization. During
treatments the horses were restrained with their heads at the height of
the withers to decrease the opening of the guttural pouch orifice to
maintain a closed high oxygen environment, though swallowing would still
result in transient openings of the orifices.12Following a minimum of two treatments the fungal plaques were seen to
begin regressing. Additionally the reported resolution or significant
improvement of 10/12 neurologic disorders is encouraging compared to the
9/18 cases of resolution reported in a larger retrospective study on
TACE.13
It is unlikely TOT and salpingopharyngostomy would have any additive
effect if done concurrently since it is unlikely the higher oxygen
tension could be achieved with the fistula. The two procedures could be
considered in series with the salpingopharyngostomy created after
initial TOT. The advantage of the salpingopharyngostomy alone is that it
is a single treatment without the need for further treatments or
hospitalization. Furthermore, while Jukic et al showed some
variations in partial pressures of gas in horses with
salpingopharyngostomies there was not significant variation in
temperature or humidity. The horses were housed in a controlled
environment during short sampling periods in that study and variations
may be greater if horses with salpingopharyngostomies are not housed in
an environmentally controlled condition.
Some of the clinical signs of this case report are difficult to
attribute directly to the mycosis infection and there was confounding
evidence of bacterial infection and other treatments. Regardless,
guttural pouch mycosis can result in severe and possibly fatal disease
as it almost did in this case report. Salpingopharyngostomy is an
alternative treatment strategy to traditional medical treatment that
should be considered in horses with guttural pouch mycosis.
References
1. Baptiste KE, Naylor JM, Bailey J, Barber EM, Post K, Thornhill J. A
function for guttural pouches in the horse. Nature .
2000;403:382-383.
2. Ludwig A, Gatineau S, Reynaud MC, Cadoré JL, Bourdoiseau G. Fungal
isolation and identification in 21 cases of guttural pouch mycosis in
horses (1998–2002). Vet J . 2005;169(3):457-461.
doi:10.1016/j.tvjl.2004.06.005
3. Jukic CC, Cowling NR, Perkins NR, Eps AW, Ahern BJ. Evaluation of the
effect of laser salpingopharyngostomy on the guttural pouch environment
in horses. Equine Vet J . 2020;52(5):752-759.
doi:10.1111/evj.13221
4. Greppi MC, Guillot J, Melloul E, Bourdoiseau G, Lepage O, Cadoré JL.
Experimental induction of mycotic plaques in the guttural pouches of
horses. Med Mycol . Published online October 4, 2016:myw073.
doi:10.1093/mmy/myw073
5. Koch DW, Ericksen KA, Easley JT, Hackett ES. Clinical outcome of
horses with guttural pouch infection following transpharyngeal
fenestration. J Am Vet Med Assoc . Published online May 5,
2022:1-5. doi:10.2460/javma.22.01.0041
6. Koch DW, Easley JT, Nelson BB, Delcambre JJ, McCready EG, Hackett ES.
Comparison of two techniques for transpharyngeal endoscopic auditory
tube diverticulotomy in the horse. J Vet Sci . 2018;19(6):835.
doi:10.4142/jvs.2018.19.6.835
7. Watkins AR, Parente EJ. Salpingopharyngeal fistula as a treatment for
guttural pouch mycosis in seven horses. Equine Vet J .
2018;50(6):781-786. doi:10.1111/evj.12830
8. Hall LA, Denning DW. Oxygen requirements of Aspergillus species.J Med Microbiol . 1994;41(5):311-315.
doi:10.1099/00222615-41-5-311
9. Dhingra S, Buckey JC, Cramer RA. Hyperbaric Oxygen Reduces
Aspergillus fumigatus Proliferation In Vitro and InfluencesIn Vivo Disease Outcomes. Antimicrob Agents Chemother .
2018;62(3):e01953-17. doi:10.1128/AAC.01953-17
10. Segal E. Hyperbaric Oxygen in the Treatment of Invasive Fungal
Infections: A Single-Center Experience. 2007;9.
11. Kaufman H, Gurevich M, Tamir E, Keren E, Alexander L, Hayes P.
Topical oxygen therapy stimulates healing in difficult, chronic wounds:
a tertiary centre experience. J Wound Care . 2018;27(7):426-433.
doi:10.12968/jowc.2018.27.7.426
12. Lepage OM, Di Francesco P, Moulin N, et al. The Effect of Topical
Oxygen Therapy in Horses Affected with Mycosis of the Guttural Pouch: An
Experimental Pilot Study and a Case Series. Anim Open Access J
MDPI . 2021;11(11):3329. doi:10.3390/ani11113329
13. Lepage OM, Piccot-Crézollet C. Transarterial coil embolisation in 31
horses (1999-2002) with guttural pouch mycosis: a 2-year follow-up.Equine Vet J . 2010;37(5):430-434. doi:10.2746/042516405774479960
14.Whitehead AE, Whitty J, Scott M, Léguillette R. Reversible dysphagia
secondary to guttural pouch mycosis in a gelding treated medically with
voriconazole and surgically with carotid occlusion and esophagostomy.Can Vet J . 2018;59(2):165-170.